Home › Non-Small Cell Lung Cancer › Florida › Plantation
Non-Small Cell Lung Cancer clinical trials in Plantation, FL
16 studies for Non-Small Cell Lung Cancer are looking for participants at sites in and around Plantation (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer.
RecruitingPhase 2/3
- Florida Clinical Trials Group, Plantation
A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)
RecruitingPhase 3
- Local Institution - 0935, Plantation
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
RecruitingPhase 3
- BRCR Global, Plantation
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
RecruitingPhase 3
- Florida Clinical Trials Group Plantation, Plantation
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
RecruitingPhase 3
- BRCR Global, Plantation
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
RecruitingPhase 3
- Florida Clinical Trials Group., Plantation
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
RecruitingPhase 3
- Clinical Study Site, Plantation
Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer
RecruitingPhase 3
- BRCR Global Plantation, Plantation
Study of Pembrolizumab + Pemetrexed + Platinum Chemotherapy With or Without Zoldonrasib as First Line Treatment in Metastatic Non-squamous RAS G12D-Mutated NSCLC
RecruitingPhase 3
- Florida Clinical Trials Group, LLC, Plantation
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
RecruitingPhase 3
- UM Sylvester Comprehensive Cancer Center at Plantation, Plantation
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
RecruitingPhase 1/2
- Boca Raton Clinical Research Associates, Plantation
A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors
RecruitingPhase 1
- Florida Clinical Trials Group, Plantation
Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer
RecruitingPhase 2
- BRCR Medical Center, Inc., Plantation
A Study of DB-1310 in Advanced/Metastatic Solid Tumors
RecruitingPhase 1/2
- BRCR global, Plantation
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
RecruitingPhase 1/2
- Research Site 101, Plantation
A Study of IBI363 in Subjects with Advanced Solid Malignancies
RecruitingPhase 2
- BRCR Medical Center, Plantation
Non-Small Cell Lung Cancer trials in other cities
- Houston, TX145 studies
- New York City, NY120 studies
- Arlington, VA104 studies
- Nashville, TN97 studies
- Boston, MA90 studies
- Los Angeles, CA87 studies
- St. Louis, MO73 studies
- Chicago, IL61 studies
- Baltimore, MD60 studies
- San Antonio, TX59 studies
- Columbus, OH56 studies
- Washington, DC55 studies
Other studies in Plantation
- Breast Cancer14 studies
- Lupus7 studies
- Cancer (all types)7 studies
- Lung Cancer7 studies
- Rheumatoid Arthritis6 studies
- Metastatic Cancer6 studies
- Colorectal Cancer5 studies
- Psoriatic Arthritis5 studies
- Prostate Cancer5 studies
- Head and Neck Squamous Cell Carcinoma4 studies
- Multiple Myeloma4 studies
- Melanoma4 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.